Multicenter evaluation of an automated assay for troponin I.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Clinical Chemistry

• Publication date

  2002-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/clinchem/48.6.869PMID 12029002
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Markers in cardiology: current and future clinical applications

  2001cited by this paper
• Myocardial infarction redefined: role of cardiac troponin testing.

  2001cited by this paper
• New generation cardiac troponin I assay for the access immunoassay system.

  2001cited by this paper
• Clinical efficacy of three assays for cardiac troponin I for risk stratification in acute coronary syndromes: a Thrombolysis In Myocardial Infarction (TIMI) 11B Substudy.

  2000cited by this paper
• Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

  2000cited by this paper
• Extensive troponin I and T modification detected in serum from patients with acute myocardial infarction.

  2000cited by this paper
• Lower cardiac troponin T and I results in heparin-plasma than in serum.

  2000cited by this paper
• Troponin T and I assays show decreased concentrations in heparin plasma compared with serum: lower recoveries in early than in late phases of myocardial injury.

  2000cited by this paper
• It's time for a change to a troponin standard.

  2000cited by this paper
• Preliminary evaluation of the Vitros ECi cardiac troponin I assay.

  2000cited by this paper
• Extensive Troponin I and T Modification Detected in Serum From Patients With Acute Myocardial Infarction

  2000cited by this paper
• Biochemical Factors Influencing Measurement of Cardiac Troponin I in Serum

  1999cited by this paper
• Proposals from IFCC Committee on Standardization of Markers of Cardiac Damage (C-SMCD): recommendations on use of biochemical markers of cardiac damage in acute coronary syndromes.

  1999cited by this paper
• Multicenter clinical and analytical evaluation of the AxSYM troponin-I immunoassay to assist in the diagnosis of myocardial infarction.

  1999cited by this paper
• National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases.

  1999cited by this paper
• Degradation of cardiac troponin I in serum complicates comparisons of cardiac troponin I assays.

  1999influential reference
• Impact of antibody specificity and calibration material on the measure of agreement between methods for cardiac troponin I.

  1999cited by this paper
• Degradation of cardiac troponin I: implication for reliable immunodetection.

  1998cited by this paper
• Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. American Association for Clinical Chemistry Subcommittee on cTnI Standardization.

  1998cited by this paper
• False increase of cardiac troponin I with heterophilic antibodies.

  1998cited by this paper
• Effects of protein kinase A phosphorylation on signaling between cardiac troponin I and the N-terminal domain of cardiac troponin C.

  1997cited by this paper
• Troponin I is released in bloodstream of patients with acute myocardial infarction not in free form but as complex.

  1997cited by this paper
• Interlaboratory/intermethod differences in functional sensitivity of immunometric assays of thyrotropin (TSH) and impact on reliability of measurement of subnormal concentrations of TSH.

  1995cited by this paper
• Coupling of calcium to the interaction of troponin I with troponin C from cardiac muscle.

  1994cited by this paper
• Random and continuous-access immunoassays with chemiluminescent detection by Access automated analyzer.

  1994cited by this paper
• Effects of Ca2+ and subunit interactions on surface accessibility of cysteine residues in cardiac troponin.

  1988cited by this paper
• Statistical methods for assessing agreement between two methods of clinical measurement.

  1986cited by this paper
• National Committee for Clinical Laboratory Standards.

  1980cited by this paper
• Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature.

  1979cited by this paper
• Fitting straight lines when both variables are subject to error.

  1978cited by this paper

• HETEROPHILE ANTIBODIES – A RARE BUT SIGNIFICANT CAUSE OF FALSE POSITIVE CARDIAC TROPONIN LEVELS

  2025cites this paper
• On the Effect of Heterophilic Antibodies on Serum Levels of Cardiac Troponins: A Brief Descriptive Review

  2022cites this paper
• Analytical Concordance of Diverse Point-of-Care and Central Laboratory Troponin I Assays.

  2019cites this paper
• Clinical impact of using a more sensitive troponin assay in patients with acute chest pain

  2019cites this paper
• The effect of prolonged exercise and environmental temperature upon left ventricular function and cardiac biomarker release

  2019cites this paper
• The Diagnostic Value of Biochemical Cardiac Markers in Acute Myocardial Infarction

  2019cites this paper
• Multi-Center Study of the 99th Percentile Value of High-Sensitivity Troponin I in A Normal Healthy Chinese Population

  2017cites this paper
• Biomarqueurs des risques cardiaque et métabolique

  2016influential citation
• Cardiac Troponin I is Increased in Patients with Polytrauma and Chest or Head Trauma. Results of A Retrospective Case-Control Study

  2016cites this paper
• The Importance of the Troponin Biomarker in Myocardial Infarction

  2016cites this paper
• Two-hour diagnostic algorithms for early assessment of patients with acute chest pain--Implications of lowering the cardiac troponin I cut-off to the 97.5th percentile.

  2015cites this paper
• Prognostic value of initial elevation in cardiac troponin I level in critically ill patients without acute coronary syndrome.

  2015cites this paper
• Nanoparticle-Assisted Immunoassays for Point-of-Care Testing - With Specific Interest in Minimally Interference-Prone Assays for Cardiac Troponin I

  2015cites this paper
• Kinetics of high-sensitivity cardiac troponin T or troponin I compared to creatine kinase in patients with revascularized acute myocardial infarction

  2015cites this paper
• Challenges in harmonizing integrated healthcare network laboratories: Multi-center evaluation of the AccuTnI+3 troponin assay.

  2015cites this paper
• Cardiac troponin I for prediction of clinical outcomes and cardiac function through 3-month follow-up after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.

  2015cites this paper
• Predictive value for death and rehospitalization of 30-day postdischarge B-type natriuretic peptide (BNP) in elderly patients with heart failure. Sub-analysis of Italian RED Study

  2015influential citation
• Novel aspects of cardiovascular biomarkers in myocardial infarction and obstructive sleep apnea

  2015cites this paper
• Low prevalence of detectable serum cardiac troponin I among healthy Tanzanian adults: observational study

  2015cites this paper
• Clinical evaluation of the troponin I assay on radiometer AQT90 FLEX and Beckman Coulter UniCel DxI 800 analyzers.

  2014cites this paper
• Evidence-based approach to harmonised reference intervals.

  2014cites this paper
• Cardiac Troponin Specific Autoantibodies: Analytical Tools for Exploring Their Impact on Cardiac Troponin I Testing

  2014influential citation
• Patients with Stable Coronary Artery Disease Receiving Chronic Statin Treatment Who Are Undergoing Noncardiac Emergency Surgery Benefit from Acute Atorvastatin Reload

  2014cites this paper
• Inhibition of inflammation mediates the protective effect of atorvastatin reload in patients with coronary artery disease undergoing noncardiac emergency surgery

  2014cites this paper
• The global need to define normality: the 99th percentile value of cardiac troponin.

  2014cites this paper
• Interference from heterophilic antibodies in troponin testing. Case report and systematic review of the literature.

  2013cites this paper
• New Risk Markers in Atrial Fibrillation

  2013cites this paper
• Acceptable Cardiac Safety Profile of Neoadjuvant 5-Fluorouracil, Epirubicin, Cyclophosphamide and Celecoxib (FEC-C) for Breast Cancer: A Subanalysis of Biomarkers for Cardiac Injury

  2013cites this paper
• VALIDACIÓN DEL TEST DE TROPONINAS EN PLASMA A PARTIR DE UNA POBLACIÓN SANA. UNA EXPERIENCIA LOCAL

  2013cites this paper
• Unexpectedly elevated cardiac troponin I level in the patient without acute coronary syndrome.

  2013cites this paper
• A comprehensive review of upper reference limits reported for (high-)sensitivity cardiac troponin assays: the challenges that lie ahead

  2012cites this paper
• Multiple immunoassay systems are negatively interfered by circulating cardiac troponin I autoantibodies

  2012cites this paper
• Analytical performances of the newly developed, fully automated Kryptor Copeptin assay: which impact factor for myocardial infarction rules out in the emergency department?

  2012cites this paper
• A pilot randomized study of ranolazine for reduction of myocardial damage during elective percutaneous coronary intervention.

  2012cites this paper
• Short-term (90 min) diagnostic performance for acute non-ST segment elevation myocardial infarction and 30-day prognostic evaluation of a novel third-generation high sensitivity troponin I assay.

  2012cites this paper
• High-sensitivity cardiac troponin assays : laboratory and clinical aspects

  2012cites this paper
• Troponin-specific autoantibody interference in different cardiac troponin I assay configurations.

  2012cites this paper
• Cardiac Biomarkers Are Associated With an Increased Risk of Stroke and Death in Patients With Atrial Fibrillation: A Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Substudy

  2012cites this paper
• Influence of hemolysis on troponin testing: studies on Beckman Coulter UniCel Dxl 800 Accu-TnI and overview of the literature

  2011cites this paper
• Clinical performance of a new point-of-care cardiac troponin I assay compared to three laboratory troponin assays.

  2011cites this paper
• The clinical significance of cardiac troponins in medical practice.

  2011cites this paper
• Proteomic biomarkers for diagnosis in acute myocardial infarction

  2011cites this paper
• Recommendations for the use of cardiac troponin measurement in acute cardiac care.

  2010cites this paper
• Short-term increase of serum troponin I and serum heart-type fatty acid-binding protein (H-FABP) in dogs following administration of formoterol.

  2010cites this paper
• Clopidogrel reloading in patients undergoing percutaneous coronary intervention on chronic clopidogrel therapy: results of the ARMYDA-4 RELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) randomized trial.

  2010cites this paper
• Effectiveness of in-laboratory high-dose clopidogrel loading versus routine pre-load in patients undergoing percutaneous coronary intervention: results of the ARMYDA-5 PRELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) randomized trial.

  2010cites this paper
• Short-term atorvastatin preload reduces levels of adhesion molecules in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Results from the ARMYDA-ACS CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy

  2010cites this paper
• Prognostic Significance of Cardiac Troponin I Levels in Hospitalized Patients Presenting With Supraventricular Tachycardia

  2010cites this paper
• Doubt on prevention of false-positive results of cardiac troponin I by recentrifugation

  2009cites this paper
• Genetic and biochemical heterogeneity of cardiac troponins: clinical and laboratory implications

  2009cites this paper
• [Analytical false-positive increases and cardiac troponin I: what is the best sample?].

  2009cites this paper
• Clinical Comparison of 99th Percentile and 10% Coefficient of Variation Cutoff Values for Four Commercially Available Troponin I Assays

  2009cites this paper
• Seemingly healthy 71‐year‐old men with minor elevations of cardiac troponin I and at risk of premature death in CVD have elevated levels of NT‐proBNP: Report from the ULSAM study

  2009cites this paper
• Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial.

  2009cites this paper
• Clinical performance of two highly sensitive cardiac troponin I assays.

  2009cites this paper
• Troponin revisited 2008: assay performance

  2008cites this paper
• Pathophysiologic mechanisms of persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome.

  2008cites this paper
• Measurement of cardiac troponins revisited

  2008cites this paper
• Higher incidence and serum levels of minor cardiac biomarker elevation in sirolimus-eluting stent (Cypher) than bare metal stent implantations

  2008cites this paper
• Prevalence and pathophysiological mechanisms of elevated cardiac troponin I levels in a population-based sample of elderly subjects.

  2008cites this paper
• Persistent Cardiac Troponin I Elevation in Stabilized Patients After an Episode of Acute Coronary Syndrome Predicts Long-Term Mortality

  2007cites this paper
• Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial.

  2007cites this paper
• Release of cardiac bio-markers during high mechanical index contrast-enhanced echocardiography in humans.

  2007cites this paper
• Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 269 Cardiac Troponins in Patients with Suspected or Confirmed Acute Coronary Syndrome New Applications for Biomarkers in Coronary Artery Disease

  2007cites this paper
• You can assay that again!

  2007cites this paper
• Early prediction of anthracycline induced cardiotoxicity

  2007cites this paper
• Heart-type fatty acid-binding protein predicts long-term mortality after acute coronary syndrome and identifies high-risk patients across the range of troponin values.

  2007cites this paper
• Safety and efficacy of short-term celecoxib before elective percutaneous coronary intervention for stable angina pectoris.

  2006cites this paper
• Troponin I as a Predictor of Coronary Heart Disease and Mortality in 70-Year-Old Men: A Community-Based Cohort Study

  2006cites this paper
• The antibody configurations of cardiac troponin I assays may determine their clinical performance.

  2006cites this paper
• Performance evaluation and subsequent clinical experience with the Abbott Automated Architect STAT Troponin-I assay.

  2006cites this paper
• [The use of cardiac troponins (T or I) measurement in cardiology and various clinical settings].

  2006cites this paper
• Present and Future Biochemical Markers for Detection of Acute Coronary Syndrome

  2006cites this paper
• Effect of seropositive rheumatoid factor on cardiac troponin I measurement using the Access® Immunoassay Analyzer

  2006cites this paper
• Positive Interference from Contrast Media in Cardiac Troponin I Immunoassays

  2006cites this paper
• Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy.

  2006cites this paper
• Defining Myocardial Infarction

  2006cites this paper
• Dosage des isoformes cardiaques des troponines T ou I : intérêt en cardiologie et en anesthésie–réanimation

  2006cites this paper
• Integration between point-of-care cardiac markers in an emergency/cardiology department and the central laboratory: methodological and preliminary clinical evaluation

  2005cites this paper
• False-positive troponin I measured with the Abbott AxSYM attributed to fibrin interference.

  2005cites this paper
• Randomized Trial of High Loading Dose of Clopidogrel for Reduction of Periprocedural Myocardial Infarction in Patients Undergoing Coronary Intervention: Results From the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) Study*

  2005cites this paper
• Comparison of cardiac troponin I immunoassays variably affected by circulating autoantibodies.

  2005cites this paper
• Comparison of cardiac troponin I levels in serum and sodium-citrate plasma using the ACCESS 2 immunoassay.

  2005cites this paper
• Measurement of troponin I 48h after admission as a tool to rule out impaired left ventricular function in patients with a first myocardial infarction

  2005cites this paper
• [Cardiac troponin I and C: analytical comparison and clinical-biological interpretation of three troponins assays].

  2005cites this paper
• Selection of antibodies and epitopes for cardiac troponin immunoassays: should we revise our evidence-based beliefs?

  2005cites this paper
• Randomized Trial of Atorvastatin for Reduction of Myocardial Damage During Coronary Intervention: Results From the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) Study

  2004cites this paper
• Clinical significance of increased cardiac troponins T and I in participants of ultra-endurance events.

  2004cites this paper
• Factor V Leiden in blood donors in Baghdad (Iraq).

  2004cites this paper
• Predictors and prognostic value of myocardial injury following stent implantation.

  2004cites this paper
• Innotrac aio! Second-generation cardiac troponin I assay: imprecision profile and other key characteristics for clinical use.

  2004cites this paper
• The interfering component in cardiac troponin I immunoassays: need for further experimental evidence.

  2004cites this paper
• Early detection of the selectivity loss of the Cobas Integra analyzer chloride ion-selective electrode.

  2004cites this paper
• Comparison of cardiac troponin T and I in healthy men and in aortic valve replacement

  2004cites this paper
• Clinical Significance of Increased Cardiac Troponins T and I in Participants of Ultra-Endurance Events

  2004cites this paper
• Beckman Access versus the Bayer ACS:180 and the Abbott AxSYM cardiac Troponin-I real-time immunoassays: an observational prospective study

  2004cites this paper
• Doit-on modifier les normes de la troponine Ic en hémodialyse ?

  2004cites this paper
• Quelle limite pour la troponine Ic : 99e percentile ou sensibilité fonctionnelle ? Comparaison des méthodes Beckman vs DPC

  2004cites this paper
• Innotrac Aio! Second-generation Cardiac Troponin I Assay: Imprecision Profile and Other Key Characteristics for Clinical Use

  2004cites this paper
• De la difficulté à comparer des résultats de troponine I cardiaque à propos de trois méthodes de dosage

  2004cites this paper